Zobrazeno 1 - 10
of 28
pro vyhledávání: '"A.O. Lisitsyn"'
Autor:
E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, E.L. Semikina, K.B. Isaeva, A.O. Lisitsyn, R.V. Denisova, E.G. Chistyakova, T.V. Sleptsova, E.V. Mitenko
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 4, Pp 94-100 (2010)
Treatment of patients with severe clinical course of juvenile rheumatoid arthritis (JRA) is difficult problem. During the last years genetically engineered biological drugs are used equally with traditional immunosuppressive agents in treatment of se
Externí odkaz:
https://doaj.org/article/350270b4b9174488a7c4b4ff642f02b5
Autor:
T.M. Bzarova, E.I. Alexeeva, S.I. Valieva, A.M. Chomakhidze, K.B. Isaeva, A.O. Lisitsyn, R.V. Denisova
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 4, Pp 147-154 (2010)
The article presents a case report of recurrent clinical course of polyarticular type of juvenile rheumatoid arthritis, which is characterized with rapid development of disability, low quality of life, high index of functional insufficiency, torpid f
Externí odkaz:
https://doaj.org/article/478f8f2e78b941ecb9eea69593cd591d
Autor:
A.O. Lisitsyn, E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, R.V. Denisova, A.M. Chomakhidze, K.B. Isaeva
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 4, Pp 27-33 (2010)
The article presents results of a study of mineral density of bone tissue in patients with juvenile arthritis treated with immunosuppressive agents and blocker of tumor necrotizing factor (TNF) alpha infliximab. Administration of immunosuppressants i
Externí odkaz:
https://doaj.org/article/7b5e013591c944629e648706a304937f
EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY AND LATE JUVENILE RHEUMATOID ARTHRITIS
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 3, Pp 30-42 (2010)
The article presents results of a study of effectiveness and safety of infliximab — monoclonal antibodies to the tumor necrotizing factor (TNF) in treatment of 100 patients11 months — 17 years old with early and late articular types of juvenile r
Externí odkaz:
https://doaj.org/article/224e9e4417ec46ffbd7dc7a403f93428
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 3, Pp 88-96 (2010)
The article presents a case report of early debut and severe clinical course of polyarticular type of juvenile rheumatoid arthritis which was refractory to the treatment with classical immunosuppressants and secondary inefficiency of chimeruc monoclo
Externí odkaz:
https://doaj.org/article/663ab8e4d30649baacfe9c148ca876f4
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 3, Pp 54-62 (2010)
The article presents literature review on the role of B-lymphocytes in pathogenesis of rheumatologic diseases and on the administration of chimeric anti-CD20 monoclonal antibodies — rituximab — for treatment of systemic lupus erythematosus, syste
Externí odkaz:
https://doaj.org/article/e4dc98b8eafa4999ad9cc7df6001e94c
Autor:
A.O. Lisitsyn, E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, R.V. Denisova, N.А. Karagulyan, A.M. Chomachidze, K.B. Isaeva
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 3, Pp 140-146 (2010)
The article presents a case report of an early debut and severe clinical course of juvenile rheumatoid arthritis with eyes’ lesion. Authors describe successful administration of human monoclonal antibodies to tumor necrotizing factor (TNF) — adal
Externí odkaz:
https://doaj.org/article/a4ae65a2d98d4758af5acec89b7dfe37
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 1, Pp 52-61 (2010)
The article observes the data on the role of interleukin (IL) 6 in pathogenesis of rheumatoid arthritis and treatment of rheumatoid arthritis and different types of juvenile arthritis with blocker IL 6 receptor (tocilizumab). The data on multicenter
Externí odkaz:
https://doaj.org/article/abc8b9d887af4a849fb880c12797b862
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 1, Pp 116-121 (2010)
This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically signifi
Externí odkaz:
https://doaj.org/article/c91e9f067cba44f68aa7d6d5a3887529
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.